
Congressional Committee Orders DEA to Crack Down on Unregulated Cannabis Products
A House committee has directed the DEA and FDA to target unregulated cannabinoid products and report on enforcement efforts, signaling heightened federal oversight of the cannabis market
- •The House Appropriations Committee is instructing the DEA and FDA to enforce action against unregulated intoxicating cannabinoid products
- •The directive requires federal agencies to report on enforcement efforts and resource needs within 90 days of the bill's enactment
- •Congress is moving forward with legislation that will recriminalize hemp-derived THC products starting in November
by Tom Angell



















